Medicine
Briviact 25 mg tablet
Briviact 25 mg tablet is a prescription medicine containing Brivaracetam for oral use, marketed by UCB, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze BRIVIACT injection or oral solution. Store at 25°C (77°F)…
Key facts
- Active ingredient (INN)
- Brivaracetam
- Brand
- Briviact
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 blister pack, 1 bottle
- Marketing authorisation holder
- UCB
- Manufacturer
- UCB
- Origin register
- US FDA, United States
- Storage
- Do not freeze BRIVIACT injection or oral solution. Store at 25°C (77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). See USP Controlled Room Temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Schedule CV
- ATC code
- N03AX23 Brivaracetam
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 May 2016
- Identifiers
- DailyMed set ID 3cf2f439-0e97-443e-8e33-25ecef616f6cNDC 50474-470Application NDA205836
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Brivaracetam 25 mg tablet.
Other strengths and forms of Brivaracetam
Clinical summary
Brivaracetam is a prescription medicine indicated for the treatment of partial-onset seizures in patients 1 month of age and older. It is available as tablets, oral solution and injection for intravenous use. MedsAcross supplies Brivaracetam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BrivaracetamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Briviact prescribing information (UCB) · U.S. National Library of Medicine, DailyMed
- Briviact (in Italy: Nubriveo): European public assessment report (EPAR) · European Medicines Agency
Need Briviact 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.